Annex to 24-27 February 2025 CHMP Agenda

Frequently asked questions (FAQs) : How to create and submit an annual safety report and respond to related requests for information - CTIS Training Programme - Module 18

Frequently asked questions (FAQs): How to create, submit and withdraw a Clinical Trial Application - CTIS Training Programme - Module 10

Minutes - PDCO minutes of the 12-15 November 2024 meeting

Vitrolife IVF media - Procedural steps and scientific information after initial consultation

Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Date of authorisation: 19/09/2005, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Awiqli, Insulin icodec, Date of authorisation: 17/05/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Alimta, pemetrexed, Date of authorisation: 20/09/2004, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): ReFacto AF, moroctocog alfa, Date of authorisation: 13/04/1999, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Viagra, sildenafil, Date of authorisation: 13/09/1998, Revision: 50, Status: Authorised